Cerity Partners LLC Sells 352 Shares of Plexus Corp. (NASDAQ:PLXS)

Cerity Partners LLC trimmed its position in Plexus Corp. (NASDAQ:PLXS) by 4.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,250 shares of the technology company’s stock after selling 352 shares during the period. Cerity Partners LLC’s holdings in Plexus were worth $1,291,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of PLXS. Pacer Advisors Inc. acquired a new stake in Plexus in the fourth quarter worth $107,489,000. Geode Capital Management LLC raised its stake in Plexus by 0.8% during the 3rd quarter. Geode Capital Management LLC now owns 653,759 shares of the technology company’s stock worth $89,392,000 after buying an additional 4,926 shares during the period. American Century Companies Inc. lifted its holdings in Plexus by 72.2% during the fourth quarter. American Century Companies Inc. now owns 544,017 shares of the technology company’s stock worth $85,128,000 after acquiring an additional 228,027 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Plexus by 146.9% in the fourth quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company’s stock valued at $40,501,000 after acquiring an additional 154,003 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of Plexus by 3.3% during the fourth quarter. Principal Financial Group Inc. now owns 138,367 shares of the technology company’s stock worth $21,652,000 after purchasing an additional 4,445 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Price Performance

Shares of PLXS opened at $122.66 on Friday. The company’s 50-day moving average is $127.54 and its 200-day moving average is $144.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The firm has a market capitalization of $3.32 billion, a PE ratio of 28.46 and a beta of 0.83. Plexus Corp. has a fifty-two week low of $92.72 and a fifty-two week high of $172.89.

Plexus (NASDAQ:PLXS) last announced its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. Equities analysts forecast that Plexus Corp. will post 5.9 EPS for the current year.

Insider Buying and Selling at Plexus

In other Plexus news, insider Michael J. Running sold 1,250 shares of Plexus stock in a transaction on Friday, February 21st. The stock was sold at an average price of $138.62, for a total value of $173,275.00. Following the completion of the transaction, the insider now directly owns 1,276 shares of the company’s stock, valued at $176,879.12. The trade was a 49.49 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 4,337 shares of the stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total value of $616,851.51. Following the sale, the chief executive officer now directly owns 80,595 shares in the company, valued at approximately $11,463,026.85. This trade represents a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,958 shares of company stock valued at $2,551,930 in the last quarter. Company insiders own 1.76% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on PLXS. Stifel Nicolaus started coverage on shares of Plexus in a report on Tuesday, February 4th. They set a “hold” rating and a $152.00 target price on the stock. Needham & Company LLC raised their target price on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Finally, Benchmark restated a “buy” rating and issued a $165.00 price objective on shares of Plexus in a research note on Wednesday, January 22nd. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Plexus presently has an average rating of “Moderate Buy” and an average target price of $163.00.

Plexus Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.